The authors of a paper that endorses a computerized test for depression have acknowledged failure to disclose joint ownership of a company formed to bring the test to market. Lead author Robert Gibbons had incorporated the company, registered to do business as Adaptive Testing Technologies, and issued shares in the company to David Kupfer (chairman of the DSM-5 task force) and three other co-authors prior to acceptance of the paper by JAMA Psychiatry. The authors failed to acknowledge the conflict either in the paper or in a reply to criticism printed in JAMA.
When is Disclosure not Disclosure? (Health Care Renewal)